Clover Health Investments, Corp CLOV
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Business overview of Clover Health Investments, Corp (CLOV)
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Key Insights
Critical company metrics and information
Latest Closing Price
$3.64Market Cap
$1.86 BillionTotal Outstanding Shares
418.53 Million SharesTotal Employees
570Dividend
No dividendIPO Date
January 8, 2021SIC Description
Hospital & Medical Service PlansPrimary Exchange
NASDAQType
Common StockHeadquarters
3401 mallory lane, suite 210, Franklin, TN, 37067Homepage
https://www.cloverhealth.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Discontinued | $144,000 |
Net Cash Flow | $33.19 Million |
Net Cash Flow From Operating Activities, Discontinued | $144,000 |
Net Cash Flow From Financing Activities, Continuing | $-4.67 Million |
Net Cash Flow From Investing Activities | $-12.13 Million |
Net Cash Flow From Investing Activities, Continuing | $-12.13 Million |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Income/Loss Attributable To Noncontrolling Interest | $0 |
Preferred Stock Dividends And Other Adjustments | $0 |
Revenues | $330.99 Million |
Diluted Average Shares | $490.18 Million |
Operating Income/Loss | $-8.79 Million |
Cost Of Revenue | $249.77 Million |
Comprehensive Income
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss | $-6.04 Million |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Comprehensive Income/Loss Attributable To Parent | $-6.04 Million |
Other Comprehensive Income/Loss | $3.11 Million |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Liabilities And Equity | $653.01 Million |
Current Liabilities | $279.63 Million |
Fixed Assets | $5.34 Million |
Prepaid Expenses | $12.95 Million |
Noncurrent Liabilities | $31.21 Million |
Other Current Assets | $419.78 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Recent Headlines From The Web
Latest news, press releases, and media coverage about CLOV from trusted financial sources
ⓒ 2025 Financhle. All Rights Reserved.